Cell line · CVCL_1714
SUP-T1
Cancer cell line, Homo sapiens. Childhood T lymphoblastic lymphoma. 50 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SUP-T1. Cell lines, record CVCL_1714. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1714
On this page
Cell line
As Cellosaurus gives it.
- Name
- SUP-T1
- Accession
- CVCL_1714
- RRID
- RRID:CVCL_1714
- Synonyms
- Sup-T1, SUPT-1, SupT-1, Sup T-1, SUP T-1, SUP T1, Sup T1, SupT1, SUPT1, Tsup-1, VB, Stanford University Pediatric T-cell line 1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 8Y
- Category
- Cancer cell line
- Diseases
- Childhood T lymphoblastic lymphoma (NCIt C7210); T-cell non-Hodgkin lymphoma (ORDO Orphanet_171918)
- Derived from
- Pleural effusion (in situ)
- Cell type
- T-cell
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers50
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Incorporation of genome-bound cellular proteins into HIV-1 particles regulates viral infection. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dimerization-dependent NOTCH receptor transactivation unveils a class of highly selective NOTCH signalling inhibitors. | FEBS J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lithium attenuates HIV-1 latency reversal in an autophagy-independent way. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia. | Res Sq | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 40909497 | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Primate retroelement exonization and sexually dimorphic IL13RA1 transcription tune type 2 immune responses. | Sci Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Intron-oriented HTLV-1 integration in an adult T-cell leukemia/lymphoma cell line sustains expression of intact ift81 mRNA. | FEBS Lett | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 50
See all 50 papersRelatives12
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | BC7 | CVCL_1E03 | Cell lines | |
| Derived from it | SUP-T1/Z29 | CVCL_M772 | Cell lines | |
| Derived from it | Sup-T1 CCR5+ H6 | CVCL_A9NU | Cell lines | |
| Derived from it | Sup-T1 CCR5+ L23 | CVCL_A9NV | Cell lines | |
| Derived from it | Sup-T1 CCR5+ M10 | CVCL_A9NW | Cell lines | |
| Derived from it | Sup-T1 Nef-ER 31 | CVCL_1H35 | Cell lines | |
| Derived from it | Sup-T1-CCR5 | CVCL_X633 | Cell lines | |
| Derived from it | Sup-T1/JI | CVCL_M773 | Cell lines | |
| Derived from it | SupT1-CIITA | CVCL_C6JB | Cell lines | |
| Derived from it | SupT1-R5 | CVCL_WU89 | Cell lines |
1 to 10 of 12
See all 12 relativesCell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1942 | ATCC | |
| BCRC | 60191 | BCRC | |
| BEI_Resources | ARP-100 | BEI_Resources | |
| BEI_Resources | ARP-150 | BEI_Resources | |
| DSMZ | ACC-140 | DSMZ | |
| ECACC | 95013123 | ECACC | |
| ICLC | HTL96007 | ICLC |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1714
GET https://conductscience.org/api/cell-lines/v1/CVCL_1714/papers?page=2